You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
+
-
Gray Colour
Green Colour
ع
Home
Ministry
About the Minister
- Minister’s CV
- Minister's Office
- Contact the Minister
MOH Officials
- Vice Ministers
- Deputy Ministers
About the Ministry
- Overview
- Vision
- Mission
- Health Indicators
- Organizational Structure
- Strategy
- Health Policies
- Achievements
- Budget
- Tenders and Procurement
- Contact Us
- Help & Support
Share Your Opinion with Us
- Prominent E-Participations
Patient Satisfaction Survey Results
Regulations
Forms
We Care About You
Unified Health File
MOH Initiatives & Projects
Knowledge Management
National E- Health Strategy
Life Events
Partnerships
About MOH Portal
Interactive Map
Awareness
Patients’ Rights
Educational Content
- First Aid
- Chronic Diseases
- Health Tips
- Healthy lifestyle
- Oral Health
- Educational Series
- Seasonal and Festival Health
- Child’s Health
- Women's Health
- Various Topics
- Elderly’s Health
Health Tools
- BMI Calculator
- IBW Calculator
- Calorie Calculator
- Best Time To Get Pregnant
- Pregnancy Due Date Calculator
- Visual Acuity Test
- Prediabetes Risk Test
- Asthma Control Test
World Health Days
Premarital Screening
Command & Control Center
Pilgrim’s Health
E-Services
Media Center
MOH News
MOH Announcements
Events and Activities
MOH Publications
Important Links
Open Data
Sign In
Sign In
MOH Portal
The Ministry
Media Center
MOH News
MOH News
Listen
Al-Omar: The National Factory for Blood Plasma Products Projected to Save the Kingdom 30% of Cost
16 October 2015
Page Content
The Deputy Minister of Health for Laboratories and Blood Banks, Dr. Ibrahim Al-Omar, highlighted that setting up a national factory for blood plasma products, for the first time in the Kingdom, in partnership with the Public Investment Fund (PIF), will be of great pharmaceutical and economic impact on the health sector. “This factory is reckoned one of the important pharmaceutical projects, and a quantum leap in health services in the Kingdom,” stated Al-Omar.
He went on adding that the project aims at getting safe and secure blood and blood products from the local genes, thus securing such blood products from a safe source. Besides, Al-Omar described the plasma products factory as a vital and strategic project, where plasma products are manufactured, Allah willing, from local blood, to be used for curative purposes. In other words, instead of importing plasma products, they will be produced locally.
He pointed out that blood products (ranging from 7 to 9 as needed) are used to treat some diseases. He labeled this project as a source of "health and national safety," explaining that the blood products are currently being imported from abroad, taking the form of drugs, including plasma and clotting factors, and this project will secure such drugs, by means of blood donation locally.
Al-Omar indicated that the drugs produced from blood products are very expensive; the Kingdom imports blood products annually with a total cost of SR 332 million. The factory is projected to save about 30% of this cost.
Comments
*
Fields must be filled in.
Show more
Add Comment
*
Fields must be filled in.
in this
Section
Media Center Summary
MOH News
Currently selected
MOH Announcements
Announcements about Private Health Sector Performance
Events and Activities
MOH Publications
RSS
Also
You may be interested
Last Update :
19 October 2015 08:34 AM
Reading times :
All Rights Reserved – Ministry of Health – Kingdom of Saudi Arabia ©
MOH News
Currently selected
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.